Hilar Cholangiocarcinoma

From the reviews:

“The purpose is to provide a reference to surgeons who are treating patients with hilar cholangiocarcinoma and to provide up-to-date information and data for all healthcare providers who treat patients with this disease. The audience includes any healthcare providers who encounter patients with hilar cholangiocarcinoma, from fellows in surgical training and attending surgeons to radiologists, pathologists, and oncologists. … This is an excellent comprehensive resource of references.” (James J. Mezhir, Doody’s Book Reviews, March, 2014)

Editor Lau is currently a Professor of Surgery at the Chinese University of Hong Kong, and an Academician of Chinese Academy of Sciences, China.